These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7920527)

  • 1. [Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases].
    Gutierez MA; Anaya JM; Cabrera GE; Vindrola O; Espinoza LR
    Rev Rhum Ed Fr; 1994 Apr; 61(4):278-85. PubMed ID: 7920527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases].
    Fojtíková M; Cerná M; Pavelka K
    Vnitr Lek; 2010 May; 56(5):402-13. PubMed ID: 20578590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia and autoimmune diseases.
    Orbach H; Shoenfeld Y
    Autoimmun Rev; 2007 Sep; 6(8):537-42. PubMed ID: 17854745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin as a modulator of B cell function: implications for SLE.
    Peeva E; Venkatesh J; Michael D; Diamond B
    Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in Reiter's syndrome.
    Jara LJ; Silveira LH; Cuéllar ML; Pineda CJ; Scopelitis E; Espinoza LR
    J Rheumatol; 1994 Jul; 21(7):1292-7. PubMed ID: 7966072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuroendocrine system in the pathogenesis of rheumatic diseases (minireview).
    Imrich R
    Endocr Regul; 2002 Jun; 36(2):95-106. PubMed ID: 12207559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin and autoimmunity.
    Shelly S; Boaz M; Orbach H
    Autoimmun Rev; 2012 May; 11(6-7):A465-70. PubMed ID: 22155203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
    El-Garf A; Salah S; Shaarawy M; Zaki S; Anwer S
    J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolactin in connective tissue diseases].
    Parada-Turska J; Targońska-Stepniak B; Majdan M
    Postepy Hig Med Dosw (Online); 2006; 60():278-85. PubMed ID: 16715039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin, dendritic cells, and systemic lupus erythematosus.
    Jara LJ; Benitez G; Medina G
    Autoimmun Rev; 2008 Jan; 7(3):251-5. PubMed ID: 18190887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin in human systemic lupus erythematosus.
    Jara LJ; Vera-Lastra O; Miranda JM; Alcala M; Alvarez-Nemegyei J
    Lupus; 2001; 10(10):748-56. PubMed ID: 11721702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and prolactin-like polypeptides in rheumatoid arthritis.
    Neidhart M; Gay RE; Gay S
    Biomed Pharmacother; 1999 Jun; 53(5-6):218-22. PubMed ID: 10424242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of bromocriptine in patients with active rheumatoid arthritis].
    Figueroa F; Carrión F; Martínez ME; Rivero S; Mamani I; González G
    Rev Med Chil; 1998 Jan; 126(1):33-41. PubMed ID: 9629752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of prolactin in immunological processes].
    Hrycek A
    Wiad Lek; 1998; 51(5-6):226-33. PubMed ID: 9737186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.